Schizophrenia News and Research

Latest Schizophrenia News and Research

Negative messages not having an impact in people with addictive behaviors

What types of public messages will most likely deter drug and alcohol abuse or dissuade people from engaging in risky behavior? Negatively framed messages may not be an effective way to reach those most in need of persuasion, suggests a new study in Psychology of Addictive Behaviors by researchers from Indiana University and Wayne State University.

26 Nov 2012

Adolescent strength linked to early mortality risk

Muscle strength in adolescence is significantly associated with the likelihood for early death, reveal results from a large study of Swedish teenagers.

23 Nov 2012

Allergies common in ADHD, tic disorder patients

A significant number of people with attention deficit/hyperactivity disorder and tic disorder also have one or more allergic diseases such as asthma or atopic dermatitis, show study results.

23 Nov 2012

Childhood abuse linked to altered gray matter in psychosis

Sexual abuse in childhood is associated with significant gray matter volume reductions in patients with psychosis, US researchers report.

23 Nov 2012

Rheumatoid arthritis patients adhere to both adalimumab, etanercept

Patients with active rheumatoid arthritis are as likely to persist with adalimumab treatment as they are with etanercept, show the results of a 2-year randomized efficacy and discontinuation study of the two tumor necrosis factor inhibitors.

23 Nov 2012

Researchers trace specific paths of chandelier cells during development into the cerebral cortex

The cerebral cortex of the human brain has been called "the crowning achievement of evolution." Ironically, it is so complex that even our greatest minds and most sophisticated science are only now beginning to understand how it organizes itself in early development, and how its many cell types function together as circuits.

23 Nov 2012

Allon Files Preliminary Shelf Prospectus

Allon Therapeutics Inc. has filed a preliminary short form base shelf prospectus with the securities commissions in each province and territory of Canada (other than Quebec).

23 Nov 2012

Study sheds light on how neural ensembles form thoughts

One of the biggest puzzles in neuroscience is how our brains encode thoughts, such as perceptions and memories, at the cellular level. Some evidence suggests that ensembles of neurons represent each unique piece of information, but no one knows just what these ensembles look like, or how they form.

22 Nov 2012

Factors linked to cognitive dysfunction in schizophrenia identified

The cognitive dysfunction regularly seen in schizophrenia patients may be associated with negative symptoms and medication-induced extrapyramidal symptoms, show study findings.

21 Nov 2012

Electrophysiology: an interview with Dr Kaylene Young

Bioelectricity is an essential part of our make-up. All cells in our body communicate by electrical activity. If an electrical charge is applied to one of our muscles it will interpret that electrical activity as a signal telling it to contract.

21 Nov 2012

Pregnant women with mental health disorders face too many barriers to stop smoking

Pregnant women with mental health disorders are facing too many barriers to help them quit smoking during pregnancy despite their willingness to accept support, finds a new study published today (21 November) in BJOG: An International Journal of Obstetrics and Gynaecology.

21 Nov 2012

MRI reveals changes in brains of people with post-concussion syndrome

MRI shows changes in the brains of people with post-concussion syndrome (PCS), according to a new study published online in the journal Radiology. Researchers hope the results point the way to improved detection and treatment for the disorder.

21 Nov 2012

NeuroDerm initiates enrollment in ND0612 Phase I trial for Parkinson's

NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.

21 Nov 2012

Psychiatric disorders reduce patient fecundity, especially in men

Findings published in the Archives of General Psychiatry show that patients with schizophrenia, autism, and anorexia nervosa have significantly fewer children compared with the general population, suggesting these conditions are under strong selection to be removed from the population.

20 Nov 2012

Nasal spray sufficient for allergic rhinitis in Japanese patients

Intranasal corticosteroid sprays can be administered as a first-line treatment for Japanese patients with seasonal allergic rhinitis, without the need to use systemic corticosteroid drugs, suggest study findings.

20 Nov 2012

CAMH psychiatrist receives Polanyi Prize for university research in Ontario

The Centre for Addiction and Mental Health (CAMH) is extremely proud to announce that psychiatrist Dr. Aristotle Voineskos, Koerner New Scientist and head of CAMH's Kimel Family Translational Imaging-Genetics Research Laboratory in the Campbell Family Mental Health Research Institute, has been named one of five winners of the prestigious Polanyi Prize for university research in Ontario.

20 Nov 2012